16
Participants
Start Date
March 10, 2021
Primary Completion Date
January 17, 2024
Study Completion Date
January 17, 2024
Epidiolex 100 mg/mL Oral Solution
Epidiolex is a schedule 5 controlled substance that is a colorless to yellow oral liquid solution that is prepackaged into 100mL vials with 5mL syringes for use. It is typically used for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet Syndrome in patients 2 years of age and older.
Placebo
Placebo is composed of dehydrated alcohol, sesame seed oil, strawberry flavor, and sucralose.
Northwell Health, Lake Success
Lead Sponsor
Collaborators (1)
Jazz Pharmaceuticals
INDUSTRY
Northwell Health
OTHER